BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 23593537)

  • 1. Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.
    Li J; Mercer E; Gou X; Lu YJ
    Am J Cancer Res; 2013; 3(2):127-51. PubMed ID: 23593537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer health disparities: An immuno-biological perspective.
    Kumar S; Singh R; Malik S; Manne U; Mishra M
    Cancer Lett; 2018 Feb; 414():153-165. PubMed ID: 29154974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variations in androgen metabolism genes and associations with prostate cancer in South African men.
    Fernandez P; De Beer PM; Van der Merwe L; Heyns CF
    S Afr Med J; 2010 Nov; 100(11):741-5. PubMed ID: 21081028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for prostate cancer racial disparities.
    Singh SK; Lillard JW; Singh R
    Front Biosci (Landmark Ed); 2017 Jan; 22(3):428-450. PubMed ID: 27814623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel germline missense mutation of the androgen receptor in African American men with familial prostate cancer.
    Hu SY; Liu T; Liu ZZ; Ledet E; Velasco-Gonzalez C; Mandal DM; Koochekpour S
    Asian J Androl; 2010 May; 12(3):336-43. PubMed ID: 20173765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of androgens and the androgen receptor in prostate cancer.
    Debes JD; Tindall DJ
    Cancer Lett; 2002 Dec; 187(1-2):1-7. PubMed ID: 12359344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer racial, socioeconomic, geographic disparities: targeting the genomic landscape and splicing events in search for diagnostic, prognostic and therapeutic targets.
    Marima R; Hull R; Mathabe K; Setlai B; Batra J; Sartor O; Mehrotra R; Dlamini Z
    Am J Cancer Res; 2021; 11(4):1012-1030. PubMed ID: 33948343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer].
    Liu JH; Li HW; Tong M; Li M; Na YQ
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):364-8. PubMed ID: 15061984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen action in the prostate gland.
    Yadav N; Heemers HV
    Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate Cancer Racial Disparities: A Systematic Review by the Prostate Cancer Foundation Panel.
    Mahal BA; Gerke T; Awasthi S; Soule HR; Simons JW; Miyahira A; Halabi S; George D; Platz EA; Mucci L; Yamoah K
    Eur Urol Oncol; 2022 Feb; 5(1):18-29. PubMed ID: 34446369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
    Shafi AA; Yen AE; Weigel NL
    Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population.
    Patiño-García B; Arroyo C; Rangel-Villalobos H; Soto-Vega E; Velarde-Félix JS; Gabilondo F; Sandoval-Ramirez L; Figuera LE
    Rev Invest Clin; 2007; 59(1):25-31. PubMed ID: 17569297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen Receptor-Related Non-coding RNAs in Prostate Cancer.
    Yang Y; Liu KY; Liu Q; Cao Q
    Front Cell Dev Biol; 2021; 9():660853. PubMed ID: 33869227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity.
    Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y
    Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk.
    Salinas CA; Austin MA; Ostrander EO; Stanford JL
    Prostate; 2005 Sep; 65(1):58-65. PubMed ID: 15810021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression.
    Ren S; Wei GH; Liu D; Wang L; Hou Y; Zhu S; Peng L; Zhang Q; Cheng Y; Su H; Zhou X; Zhang J; Li F; Zheng H; Zhao Z; Yin C; He Z; Gao X; Zhau HE; Chu CY; Wu JB; Collins C; Volik SV; Bell R; Huang J; Wu K; Xu D; Ye D; Yu Y; Zhu L; Qiao M; Lee HM; Yang Y; Zhu Y; Shi X; Chen R; Wang Y; Xu W; Cheng Y; Xu C; Gao X; Zhou T; Yang B; Hou J; Liu L; Zhang Z; Zhu Y; Qin C; Shao P; Pang J; Chung LWK; Xu J; Wu CL; Zhong W; Xu X; Li Y; Zhang X; Wang J; Yang H; Wang J; Huang H; Sun Y
    Eur Urol; 2018 Mar; 73(3):322-339. PubMed ID: 28927585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Trends and Prostate Cancer: A Review of Incidence, Detection, and Mortality as Influenced by Race, Ethnicity, and Geographic Location.
    Taitt HE
    Am J Mens Health; 2018 Nov; 12(6):1807-1823. PubMed ID: 30203706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial Stress, Glucocorticoid Signaling, and Prostate Cancer Health Disparities in African American Men.
    Woods-Burnham L; Stiel L; Martinez SR; Sanchez-Hernandez ES; Ruckle HC; Almaguel FG; Stern MC; Roberts LR; Williams DR; Montgomery S; Casiano CA
    Cancer Health Disparities; 2020; 4():. PubMed ID: 35252767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk Between AR and Wnt Signaling Promotes Castration-Resistant Prostate Cancer Growth.
    Luo J; Wang D; Wan X; Xu Y; Lu Y; Kong Z; Li D; Gu W; Wang C; Li Y; Ji C; Gu S; Xu Y
    Onco Targets Ther; 2020; 13():9257-9267. PubMed ID: 32982312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.